PACLITAXEL | N216338 | TEVA PHARMACEUTICALS INC
18 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| Nov 24, 2023 | SUPPL -1 | View Letter (PDF) |
| May 12, 2023 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.